China Medicine Corporation
CHME · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Revenue | $64,751 | $53,648 | $42,105 | $23,992 |
| % Growth | 20.7% | 27.4% | 75.5% | – |
| Cost of Goods Sold | $45,767 | $38,075 | $29,708 | $15,017 |
| Gross Profit | $18,984 | $15,573 | $12,397 | $8,975 |
| % Margin | 29.3% | 29% | 29.4% | 37.4% |
| R&D Expenses | $1,454 | $840 | $652 | $294 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5,264 | $3,805 | $3,331 | $1,565 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6,718 | $4,645 | $3,983 | $2,791 |
| Operating Income | $12,266 | $10,928 | $8,414 | $6,184 |
| % Margin | 18.9% | 20.4% | 20% | 25.8% |
| Other Income/Exp. Net | -$7,314 | $86 | $15 | -$200 |
| Pre-Tax Income | $4,952 | $11,013 | $8,430 | $5,984 |
| Tax Expense | $3,550 | $2,006 | $1,649 | $1,230 |
| Net Income | $1,718 | $9,126 | $6,875 | $4,788 |
| % Margin | 2.7% | 17% | 16.3% | 20% |
| EPS | 0.11 | 0.6 | 0.56 | 0.65 |
| % Growth | -81.7% | 7.1% | -13.8% | – |
| EPS Diluted | 0.11 | 0.6 | 0.5 | 0.63 |
| Weighted Avg Shares Out | 15,268 | 15,173 | 12,346 | 7,352 |
| Weighted Avg Shares Out Dil | 15,411 | 15,309 | 13,658 | 7,654 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,012 | $421 | $784 | $162 |
| EBITDA | $13,278 | $11,349 | $9,199 | $6,346 |
| % Margin | 20.5% | 21.2% | 21.8% | 26.5% |